Posted on 4 月 20, 20224/20/22
Navigating the Complexities of Patient Care with Digital and Human Touchpoints
Posted on 4 月 19, 20224/19/22
Pharmaceutical Distribution – Right-Sizing the Channel Strategy for Maximum Impact
Posted on 4 月 18, 20224/18/22
FDA Moves Cybersecurity Into the Product Life Cycle
Posted on 4 月 6, 20224/6/22
Reframing the Challenges of Access and ROI
Posted on 3 月 23, 20223/23/22
How Do We Pay for a Cure? How to Put a Price on Life-changing Treatments
Posted on 3 月 2, 20223/2/22
Succeed When Others Fail: Avoiding 20% in Investment Waste During Launch
Posted on 1 月 11, 20221/11/22
A YEAR OF ACTION: Why Data-Backed, Integrated Commercialization Strategies Are Must-haves in 2022
Posted on 12 月 28, 202112/28/21
The Power to Know When: Balancing High-Tech and High-Touch Solutions to Eliminate Access, Affordability and Adherence Barriers
Posted on 11 月 1, 202111/1/21
The Need for RWE Studies in APAC and the Impact on Product Life Cycle Management
Posted on 10 月 26, 202110/26/21